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Mexiletine-responsive Erythromelalgia Due To A New NaV1.7 Mutation
Showing Use-dependent Block
Jin-Sung Choi1,2, Lili Zhang3, Sulayman D. Dib-Hajj1,2, Chongyang Han1,4,
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Inherited erythromelalgia (IEM), characterized by episodic burning pain and
erythema of the extremities, is produced by gain-of-function mutations in so-
dium channel Nav1.7, which is preferentially expressed in nociceptive and sym-
pathetic neurons. Most patients do not respond to pharmacotherapy, although
a few patients have been reported as showing partial relief with lidocaine or
mexiletine. We report here a new IEM Nav1.7 mutation and its favorable re-
sponse to mexiletine. SCN9A exons from the proband were amplified and se-
quenced. Whole-cell patch-clamp analysis was used to characterize wild-type
and mutant Nav1.7 channels in mammalian cells. A 7-year-old girl, with
a two-year history of symmetric burning pain and erythema in her hands and
feet, was diagnosed with erythromelalgia. Treatment with mexiletine reduced
the number and severity of pain episodes. We identified a single nucleotide sub-
stitution (T2616G) in exon 15, not present in 200 ethnically-matched control
alleles, which substitutes valine 872 by glycine (V872G) within DII/S5.
V872G shifts activation by -10 mV, slows deactivation, and generates larger
ramp currents. We observed a stronger use-dependent inhibition by mexiletine
of V872G compared to wild-type channels. The NaV1.7/V872G mutation pro-
vides a molecular basis for DRG hyperexcitability which can produce pain.
While most IEM patients do not respond to pharmacotherapy, this patient
displayed a favorable response to mexiletine, which appears to be due to
use-dependent block of mutant channels. Continued relief from pain, even after
mexiletine was discontinued in this patient, might suggest that early treatment
may slow the progression of the disease.
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Biophysical Characterization Of Duloxetine Activity On Voltage-gated
Sodium Channels Involved In Pain Transmission
Jean-francois Rolland, David Madge, John Ford, Marc Rogers.
Xention Limited, Cambridge, United Kingdom.
Duloxetine, an inhibitor of the serotonin-norepinephrine reuptake system, is
widely used for the treatment of major depression and has also been found to
be effective in reducing neuropathic pain. This latter effect is believed to be re-
lated to the role of the two neurotransmitters in inhibiting pain signals at the
level of spinal and supraspinal neural circuits. However the possibility that du-
loxetine also acts through alternative mechanisms has not yet been investigated.
In this study we focused on the potential effect of duloxetine on neuronal
isoforms of voltage-gated sodium channels (NaV1.3 and NaV1.7) that have
a pivotal role in the generation and propagation of pain signals. Conventional
whole-cell patch-clamp recordings were performed on CHO-cells expressing
hNaV1.3 and hNaV1.7. Duloxetine exerted a concentration-dependent resting
block, measured by the reduction of the sodium current elicited by a single de-
polarizing step from -100mV to 0mV for 10 ms, with IC50 values of 5 and 16
microM for NaV1.3 and NaV1.7, respectively. These values were halved at
holding potentials that reduce channel availability of both channels by 50%, in-
dicating a preference for the inactivated state of sodium channels. Furthermore
we observed that 10 microM duloxetine induced a 10mV negative shift of the
steady state inactivation curves, and preliminary results indicate that this effect
is correlated with stabilization of slow inactivation. Finally, for both sodium
channel isoforms, an additional 20% inhibition over the resting block was ob-
served at concentrations close to the IC50 when the stimulation frequency was
increased up to 10Hz. Thus, the antidepressant duloxetine exhibits most of the
state-dependent mechanisms of a classic sodium channel blocker. These results
may add valuable information about the pharmacological spectrum of duloxe-
tine, an issue of high clinical impact considering its increasingly widespread use.
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Biophysics Of Inhibition Of hNav1.3 And hNav1.7 Channels By A-803467
Victor I. Ilyin, Kevin P. Carlin, Gang Wu.
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It has been recently published that a small molecule, A-803467, selectively in-
hibits hNav1.8 sodium channel subtype and is also efficacious in a variety of
pre-clinical pain models (ref. 1). While A-803467 blocks hNav1.8 with an
IC50 value of 8 nM (at half-maximal inactivation), it also inhibits other sodium
channel subtypes with a selectivity ratio of 30-1000-fold. In particular, it in-
hibits hNav1.3 and hNav1.7 channels, which have connection to pain sensationin animal models (ref. 2), with IC50 values around 1 mM. We suggest that in-
hibition of these channels may also contribute to analgesic efficacy of A-
803467. We therefore were interested in studying biophysical parameters of in-
teraction of A-803467 with hNav1.7 and hNav1.3 channels. We present the data
on the affinity of binding of the drug to the resting and inactivated states of the
channels, as well as the on-rate of binding to inactivated channels, retardation
of repriming and use-dependent block of trains of depolarizing pulses. The bio-
physical profile of A-803467 suggests interaction with a site distinct from the
‘‘classical’’ local anaesthetic receptor site in Nav channels. This profile is com-
pared with the parameters measured for other clinically relevant analgesics.
(1) Jarvis MF, et al. Proc Natl Acad Sci USA 2007; 104:8520-85.
(2) Dib-Hajj SD, et al. Trends in Neurosciences 2007; 30 (11):555-63.
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Recently we indirectly determined the gating charge of single Na-channels
(qNa) to be about 6 e (Gamal El-Din et al., 2008). We compared the ratios
of total fluorescence intensity to total gating charge (Ft/Qt) of EGFP marked
K- and Na-channels expressed in Xenopus laevis oocytes. This allowed to de-
duce qNa from the better known K-channels (qK¼ 13-14 e) without the need to
know the fluorescence intensity of a single EGFP (Fs). Since we used EGFP to
mark and count both channel types, Fs cancelled out in the comparison.
We now attempt to determine and apply Fs to obtain the total number of chan-
nels (Nt ¼ Ft/Fs) and from that q ¼ Qt/Nt directly. As outlined in the above
cited study, Ft was extrapolated to the whole oocyte’s surface from a defined
region along the circumference in order to minimize contributions from sub-
membraneous channels and cytoplasmic autofluorescence. Micrographs of
EGFP solutions of known concentration in a hemocytometer chamber provided
a figure for Fs. However, this figure cannot simply be transferred to the situation
of the oocyte images because it holds true only for EGFP molecules in frontal
areas, accessible for the entire opening of the microscope objective. At lateral
areas of the oocyte the fluorescence intensity is attenuated. The attenuation
was determined by measuring the fluorescence intensity of control oocytes
whose surface was strongly and homogeneously stained with a fluorescent dye
such that autofluorescence from the cytoplasm could be neglected. Comparison
of the extrapolation from either the lateral or the frontal area to the total fluores-
cence of the oocyte (Ft) gave an attenuation factor of 3 to 6 depending on the
optics. This factor was used to obtain the number of EGFP marked channels.
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Measuring The Contribution Of S4 Charges On Gating Currents Of A
Sodium Channel
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Upon membrane depolarization, conformational changes in the S4 voltage sen-
sors results in the opening of the voltage-gated sodium channel. The movement
of the positively charged residues on the four distinct voltage-sensors in the
membrane electric field generates a measurable transient current referred to
as the gating current. The ON gating currents of the Naþ channel has two ki-
netic components and the fast component correlates well with the kinetics of
fluorescence changes of probes attached to the voltage sensors of domains I,
II, and III. The slow component of the gating current, however, matches with
the fluorescence kinetics of probes on domain IV voltage-sensor (Chanda
and Bezanilla JGP 2002 120; 629-45). In an attempt to specify the molecular
origin of the slow and fast components of the gating current, we neutralized
the first three charged residues (Q3 mutants) in each of the four voltage-sensing
segments of the sodium channel. Our data supports the hypothesis that the volt-
age-sensor of domain IV primarily contributes to the slow component of the
gating current and provides support to the notion that the movement of this
voltage sensor is slower than the opening of the pore.
1294-Pos Board B138
Gateless Gating Model vs. Gated Pore Model: Phase Pinning of Guanidi-
nium Toxins in Sodium Channels
H. Richard Leuchtag.
Retired, Kerrville, TX, USA.
Unlike the gated pore model, which assumes the existence of a movable gate
within the molecule, the gateless gating model (H. R. Leuchtag, Voltage-Sen-
sitive Ion Channels, Springer 2008) (VSIC) explains ion-channel gating as
a phase transition. Under this model, the closed channel conformation imposed
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critical temperature, hysteresis, fractional dispersion exponent (constant phase
angle) and Curie-Weiss law, similar to that of phases seen in ferroelectric liquid
crystals (VSIC, pp. 355-383). In the absence of a toxin molecule, threshold
membrane depolarization indirectly brings about a stochastic phase transition
to a less ordered phase in which S4 segments expand by the mutual repulsion
of their positively charged residues. The resulting wider pitch of permeation
pathway a helices elastically linked to the S4s permits ion replacement in
the interloop H bonds and the subsequent percolation of permeant ions through
the channel (VSIC, 477f, 506f). With an externally applied tetrodotoxin (TTX)
or analog molecule complexed in the channel, however, the ordered phase is
pinned by the toxin, inhibiting the transition to the ion-conducting phase
(VSIC, 76, 382f). Phase pinning by impurities is an established effect in ferro-
electric liquid crystals. In the toxin, a guanidinium group, H2N
þ¼C(NH2)2,
a highly resonant, planar, positive ion, is active in pinning the closed phase.
The fact that guanidinium is also found in ferroelectric crystals such as guani-
dinium aluminum sulfate hexahydrate suggests that TTX enhances the sponta-
neous polarization of the resting phase. This explanation by the gateless gating
model of specific toxin action is based on physical principles; in contrast, the
phrase ‘‘TTX blocks the pore’’ offered by the gated pore model is vague and
at the macroscopic rather than molecular scale.
1295-Pos Board B139
Self-organized Models of Selectivity in Ca and Na Channels
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A simple pillbox model with two adjustable parameters accounts for selectivity
of both DEEA Ca channels and DEKA Na channels in many solutions of dif-
ferent composition and concentration. Only side chains are different in the
model of Ca and Na channels. Parameters are the same for both channels in
all solutions. ‘Pauling’ radii are used for ions. No information from crystal
structures is used. Side chains are over-approximated as spheres. Predicted
properties of Na and Ca channels are very different. How can a simple model
give such powerful results when chemical intuition says that selectivity
depends on the precise relation of ions and side chains? We use Monte Carlo
simulations of this model that determine the most stable — the lowest free
energy — structure of ions and side chains. Structure is the computed conse-
quence of the forces in this model. Forces are steric repulsion and electrostatic
attraction of ions crowded into a small space, modified by protein polarization.
The relationship of ions and side chains varies with ionic solution and is very dif-
ferent in Na and Ca channels. Selectivity is a consequence of the ‘induced fit’ of
side chains to ions and depends on flexibility (entropy) of side chains as well as
their location. The model captures the relation of side chains and ions well
enough to account for selectivity of both Na and Ca channels in the many con-
ditions measured in experiments. Evidently, the structures in the real Na and
Ca channels responsible for selectivity are self-organized, at their free energy
minimum, close to the positions computed in our model. Oversimplified models
are enough to account for selectivity if the models calculate the ‘most stable’
structure, as it changes from solution to solution, and mutation to mutation.
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of the Bacterial Voltage Gated Sodium Channel Nachbac
Andrias O. O’Reilly, Kalypso Charalambous, Ghasem Nurani,
B.A. Wallace.
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NaChBac from B. halodurans is a bacterial homologue of the eukaryotic volt-
age-gated sodium channels which has been expressed and purified from E. coli.
We have previously shown (Nurani et al (2008) Biochemistry 31:8114-8121)
that this membrane protein,, purified from E. coli, forms a mostly helical,
tetrameric detergent-solubilisable protein that is capable of binding the drug
mibefradil and inducing sodium flux when reconstituted into vesicles. The tet-
rameric quaternary structure of NaChBac differentiates it from the single-chain
eukaryotic sodium channels.
The aim of the present study was to produce a more thermally-stable version of
this ion channel which would be suitable for a wide range of structural and
functional studies. Using molecular modelling techniques, we have designed
a mutant, G219S, which incorporates a serine instead of a glycine at the pro-
posed site which is proposed to form the hinge which enables opening and clos-
ing of the channel. The aim was to reduce flexibility and ‘‘lock’’ the protein in
a single state. Mutant protein was cloned, expressed and purified from E. coli
and compared with the wild type protein isolated in the same manner. Whilst it
had a similar secondary structure, thermal melting curves monitored by circulardichroism spectroscopy indicated that the mutant was considerably more stable
than the wild type protein, although it is still capable of binding mibefradil.
Thus the protein produced had the properties as designed and is a particularly
suitable candidate for new structural, functional and drug binding studies.
(Supported by grants from the BBSRC to BAW and the MPSI Consortium)
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Ion Pair Formation During Activation of the NaChBac Voltage Sensor
Paul G. DeCaen, Todd Scheuer, William A. Catterall.
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S4 transmembrane segments of voltage-gated ion channels move outward upon
depolarization initiating a conformational change that opens the pore. Forma-
tion of ion pairs between gating-charge-carrying arginine residues in S4 and
negatively charged amino acid residues in neighboring transmembrane seg-
ments is an essential feature of the sliding helix model of gating (Catterall,
1986; Guy and Seetharamulu, 1986; Yarov-Yarovoy et al., PNAS, 2006). We
studied NaChBac mutants in which E70 in the S2 segment and the fourth gating
charge of S4 (R4) were replaced with cysteines. As previously reported for
D60:R3 (DeCaen et al. PNAS, 2008), activation of the E70C:R4C reduced
INa irreversibly but had no effect on WT or single mutants. Application of
the reducing agent b-mercaptoethanol restored INa, suggesting reversal of disul-
fide bond formation between E70 and R4. The voltage dependence of disulfide
locking matched the voltage dependence of activation (V1/2 z -75 mV). Fast
deactivation was blocked, and the loss of current upon repolarization was
slowed to the rate of inactivation (z330ms). Evidently, depolarization drives
movement of the S4 segment that allows disulfide locking of R4C and E70C,
and this activated state of the voltage sensor signals opening of the pore and
then inactivation of the channel. These data suggest that gating charge R4
forms an ion pair with E70 during activation and that the side chains of these
residues approach within ~2 A˚, as required for rapid formation of disulfide
bonds in the E70C:R4C mutant. This new molecular interaction allows further
refinement of the ROSETTA sliding helix model of gating (see adjacent poster
by Yarov-Yarovoy et al). Supported by NIH Grants T32 GM07270 (PGD) and
R01 NS157561 (WAC).
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Structural Modeling of Intermediate States of the Gating Pore of NaChBac
Vladimir M. Yarov-Yarovoy, Paul DeCaen, Todd Scheuer,
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Voltage-gated sodium channels initiate action potentials in excitable cells.
Despite progress in determining the structures of voltage-gated potassium
channels, the high-resolution structure of the voltage-gated sodium channels
remains unknown. We used the Rosetta-Membrane method (Yarov-Yarovoy
et al. Proteins 62, 1010, PNAS 103, 7292) and experimental data suggesting
proximity between E70 in S2 and R4 in S4 during activation of NaChBac to
construct structural models of intermediate states during channel gating. The
structure of the Kv1.2-Kv2.1 chimera channel in the open state (Long et al.
(2007) Nature 450, 376) was used as a template and proximity between Cb
atoms of E70 in S2 and R4 in S4 was favored during modeling. The resulting
structural models suggest a molecular mechanism of the voltage-dependent
activation of NaChBac in which S4 rotates clockwise (as viewed from the ex-
tracellular side of the membrane) and translates outward, as proposed in the
‘sliding helix’ model of gating, while gating-charge-carrying arginines in S4
sequentially interact with negatively charged residues in the S1, S2, and S3 seg-
ments. Transition through a local 3-10 helical conformation of a short segment
of S4 containing two gating-charge-carrying arginines in the narrow part of the
gating pore is required for simultaneous interaction with their ion pair partners
during activation. The side chain of highly conserved F67 in S2 is oriented side-
ways away from the gating pore to allow the long side chains of arginines in S4
to pass through the middle of the gating pore. Outward motion of the S4 seg-
ment is coupled to lateral movement of the S4-S5 linker and movements of
the S5 and S6 segments that open the intracellular gate of the pore-forming
module. Supported by NIMHGrant K01MH67625 (to V.Y.-Y.) and NIH Grant
R01 NS15751 (to W.A.C.).
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The voltage dependent sodium channel is responsible for the upstroke and di-
rected propagation of action potentials in nerve and muscle cells, and is there-
fore a central ion channel in excitable tissues. The implication of voltage gated
sodium channels in pain mediation, and diseases such as epilepsy and cardiac
arrythmia has made them very important targets for drug discovery. Nine
